Biggest News Aggregation in the World
📰 Solid Biosciences News

Solid Biosciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Solid Biosciences. Real-time updates on events, politics, business and more.

Solid Biosciences (NASDAQ:SLDB) vs. OKYO Pharma (NASDAQ:OKYO) Head-To-Head Comparison

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and OKYO Pharma (NASDAQ:OKYO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of […]
United States City Of United Kingdom University Of Missouri University Of Washington Ultragenyx Pharmaceutical Inc

Solid Biosciences Inc. to Post Q2 2024 Earnings of ($0.72) Per Share, HC Wainwright Forecasts (NASDAQ:SLDB)

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Analysts at HC Wainwright reduced their Q2 2024 EPS estimates for Solid Biosciences in a research note issued to investors on Monday, May 20th. HC Wainwright analyst A. He now anticipates that the company will post earnings per share of ($0.72) for the quarter, down from their […]
United States William Blair Piper Sandler Vanguard Group Inc Bain Capital Life Sciences Investors Artal Group

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of "Buy" from Analysts

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued a report on […]
United States William Blair Piper Sandler Vanguard Group Inc Janus Henderson Group Solid Biosciences Inc

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Average Recommendation of "Buy" from Brokerages

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been given a consensus recommendation of “Buy” by the six analysts that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued a report on […]
United States William Blair Piper Sandler Janus Henderson Group Vanguard Group Inc Solid Biosciences Inc

Financial Contrast: Solid Biosciences (NASDAQ:SLDB) & Century Therapeutics (NASDAQ:IPSC)

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Century Therapeutics (NASDAQ:IPSC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, risk and analyst recommendations. Earnings and Valuation This table compares Solid […]
United States University Of Washington Century Therapeutics Inc Ultragenyx Pharmaceutical Inc Solid Biosciences Inc University Of Florida
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Comparing Ambrx Biopharma (NYSE:AMAM) and Solid Biosciences (NASDAQ:SLDB)

Solid Biosciences (NASDAQ:SLDB – Get Free Report) and Ambrx Biopharma (NYSE:AMAM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation. Profitability This table compares Solid Biosciences and […]
United States La Jolla Ambrx Biopharma Solid Biosciences Inc Ambrx Biopharma Inc Ultragenyx Pharmaceutical Inc

Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Buy" by Brokerages

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock […]
United States Piper Sandler Kevin Tan William Blair Asset Management Inc Vanguard Group Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science